|
|
|
|
Dendritic cell maturation,but not type I interferon exposure,restricts infection by HTLV-1,and viral transmission to T-cells
|
|
|
|
|
|
|
|
نویسنده
|
rizkallah g. ,alais s. ,futsch n. ,tanaka y. ,journo c. ,mahieux r. ,dutartre h.
|
|
منبع
|
plos pathogens - 2017 - دوره : 13 - شماره : 4
|
|
چکیده
|
Human t lymphotropic virus type 1 (htlv-1) is the etiological agent of adult t cell leukemia/lymphoma (atll) and htlv-1-associated myelopathy/tropical spastic paraparesis (ham/tsp). both cd4+t-cells and dendritic cells (dcs) infected with htlv-1 are found in peripheral blood from htlv-1 carriers. we previously demonstrated that monocyte-derived il-4 dcs are more susceptible to htlv-1 infection than autologous primary t-cells,suggesting that dc infection precedes t-cell infection. however,during blood transmission,breast-feeding or sexual transmission,htlv-1 may encounter different dc subsets present in the blood,the intestinal or genital mucosa respectively. these different contacts may impact htlv-1 ability to infect dcs and its subsequent transfer to t-cells. using in vitro monocyte-derived il-4 dcs,tgf-β dcs and ifn-α dcs that mimic dcs contacting htlv-1 in vivo,we show here that despite their increased ability to capture htlv-1 virions,ifn-α dcs restrict htlv-1 productive infection. surprisingly,we then demonstrate that it is not due to the antiviral activity of type–i interferon produced by ifn-α dcs,but that it is likely to be linked to a distinct trafficking route of htlv-1 in il-4 dcs vs. ifn-α dcs. finally,we demonstrate that,in contrast to il-4 dcs,ifn-α dcs are impaired in their capacity to transfer htlv-1 to cd4 t-cells,both after viral capture and trans-infection and after their productive infection. in conclusion,the nature of the dcs encountered by htlv-1 upon primo-infection and the viral trafficking route through the vesicular pathway of these cells determine the efficiency of viral transmission to t-cells,which may condition the fate of infection. © 2017 rizkallah et al.
|
|
|
|
|
آدرس
|
international center for research in infectiology,retroviral oncogenesis laboratory,inserm u1111 –université claude bernard lyon 1,cnrs,umr5308,ecole normale supérieure de lyon,université lyon,lyon,france,equipe labellisée ligue nationale contre le cancer,lyon, France, international center for research in infectiology,retroviral oncogenesis laboratory,inserm u1111 –université claude bernard lyon 1,cnrs,umr5308,ecole normale supérieure de lyon,université lyon,lyon,france,equipe labellisée ligue nationale contre le cancer,lyon, France, international center for research in infectiology,retroviral oncogenesis laboratory,inserm u1111 –université claude bernard lyon 1,cnrs,umr5308,ecole normale supérieure de lyon,université lyon,lyon,france,equipe labellisée ligue nationale contre le cancer,lyon, France, department of immunology,graduate school of medicine,university of the ryukyus,uehara 207,nishihara-cho,okinawa, Japan, international center for research in infectiology,retroviral oncogenesis laboratory,inserm u1111 –université claude bernard lyon 1,cnrs,umr5308,ecole normale supérieure de lyon,université lyon,lyon,france,equipe labellisée ligue nationale contre le cancer,lyon, France, international center for research in infectiology,retroviral oncogenesis laboratory,inserm u1111 –université claude bernard lyon 1,cnrs,umr5308,ecole normale supérieure de lyon,université lyon,lyon,france,equipe labellisée ligue nationale contre le cancer,lyon, France, international center for research in infectiology,retroviral oncogenesis laboratory,inserm u1111 –université claude bernard lyon 1,cnrs,umr5308,ecole normale supérieure de lyon,université lyon,lyon,france,equipe labellisée ligue nationale contre le cancer,lyon, France
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|